EXPECTANT MANAGEMENT OF NONPALPABLE PROSTATE CANCER WITH CURATIVE INTENT: PRELIMINARY RESULTS
Author:
Affiliation:
1. From the Departments of Urology and Pathology, The Johns Hopkins University School of Medicine, The James Buchanan Brady Urological Institute, The Johns Hopkins Hospital, Baltimore, Maryland
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Urology
Reference6 articles.
1. The Prostate Cancer Intervention Versus Observation Trial: a randomized trial comparing radical prostatectomy versus expectant management for the treatment of clinically localized prostate cancer.;Wilt;J Urol,1994
2. Prospective characterization of pathological features of prostatic carcinomas detected via serum prostate specific antigen based screening;Humphrey;J Urol,1996
3. Pathologic and clinical findings to predict tumor extent of non-palpable (stage T1c) prostate cancer;Epstein;JAMA,1994
4. Mean time to cancer-specific death of apparently clinically localized prostate cancer: policy implications for threshold ages in prostate-specific antigen screening and ablative therapy.;Horan;BJU Int,2000
5. Prospective evaluation of men with stage T1c adenocarcinoma of the prostate;Carter;J Urol,1997
Cited by 194 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The CONFIRM trial protocol: the utility of prostate‐specific membrane antigen positron emission tomography/computed tomography in active surveillance for prostate cancer;BJU International;2023-11-13
2. Active Surveillance for Prostate Cancer: Past, Current, and Future Trends;Journal of Personalized Medicine;2023-04-03
3. Low-volume grade group 2 prostate cancer candidates for active surveillance: a radical prostatectomy retrospective analysis;Scandinavian Journal of Urology;2023-01-23
4. Neoplasms of the Prostate;Holland‐Frei Cancer Medicine;2022-10-21
5. Intensity of observation with active surveillance or watchful waiting in men with prostate cancer in the United States;Prostate Cancer and Prostatic Diseases;2022-07-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3